Bardhan K D, Morris P, Thompson M, Dhande D S, Hinchliffe R F, Jones R B, Daly M J, Carroll N J
District General Hospital, Rotherham.
Gut. 1990 Jul;31(7):745-9. doi: 10.1136/gut.31.7.745.
Forty five patients with refractory oesophagitis, defined as persisting erosive changes or ulceration despite a minimum of three months' treatment with cimetidine 3.2 g daily or ranitidine 0.9 g daily, were treated in an open trial with omeprazole 40 mg daily for up to eight weeks. Endoscopically defined healing was observed in 73% of patients after four weeks' treatment and in 91% after eight weeks' treatment. Symptoms were completely relieved in 60% of patients, improved in 34%, unchanged in 4%, and worsened in 2%. After healing patients returned to maintenance treatment with cimetidine 1.6-3.2 g daily, depending on the severity of their illness before treatment with omeprazole. By six months and 12 months only 55% and 33% of patients respectively were still in remission. This study suggests that when erosive oesophagitis is refractory to treatment with high dose cimetidine or ranitidine, treatment with omeprazole 40 mg daily for up to eight weeks is effective in inducing healing and relieving symptoms.
45例难治性食管炎患者,定义为尽管每天使用3.2克西咪替丁或0.9克雷尼替丁至少治疗3个月仍持续存在糜烂性改变或溃疡,在一项开放试验中接受每日40毫克奥美拉唑治疗长达8周。治疗4周后,73%的患者经内镜检查确定愈合,治疗8周后为91%。60%的患者症状完全缓解,34%改善,4%无变化,2%恶化。愈合后,患者根据奥美拉唑治疗前疾病的严重程度,恢复每日1.6 - 3.2克西咪替丁的维持治疗。到6个月和12个月时,分别只有55%和33%的患者仍处于缓解状态。这项研究表明,当糜烂性食管炎对高剂量西咪替丁或雷尼替丁治疗无效时,每日40毫克奥美拉唑治疗长达8周可有效促进愈合并缓解症状。